Filtered By:
Source: The Lancet Neurology
This page shows you your search results in order of relevance. This is page number 14.
Order by Relevance | Date
Total 249 results found since Jan 2013.
Optimal stroke prevention in patients with patent foramen ovale
Publication date: Available online 16 October 2018Source: The Lancet NeurologyAuthor(s): Bernhard Meier
Source: The Lancet Neurology - October 17, 2018 Category: Neurology Source Type: research
Stroke research in 2018: extended time windows, refined benefit, and lifestyle prevention targets
Publication date: January 2019Source: The Lancet Neurology, Volume 18, Issue 1Author(s): Joanna M Wardlaw, Philip M Bath
Source: The Lancet Neurology - December 14, 2018 Category: Neurology Source Type: research
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
Publication date: Available online 25 January 2019Source: The Lancet NeurologyAuthor(s): Gil I Wolfe, Henry J Kaminski, Inmaculada B Aban, Greg Minisman, Hui-Chien Kuo, Alexander Marx, Philipp Ströbel, Claudio Mazia, Joel Oger, J Gabriel Cea, Jeannine M Heckmann, Amelia Evoli, Wilfred Nix, Emma Ciafaloni, Giovanni Antonini, Rawiphan Witoonpanich, John O King, Said R Beydoun, Colin H Chalk, Alexandru C BarboiSummaryBackgroundThe Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone (MGTX) showed that thymectomy combined with prednisone was superior to prednisone alone in improving clinical sta...
Source: The Lancet Neurology - January 26, 2019 Category: Neurology Source Type: research
Dementia risk after transient ischaemic attack and stroke
Publication date: March 2019Source: The Lancet Neurology, Volume 18, Issue 3Author(s): Martin Dichgans
Source: The Lancet Neurology - February 14, 2019 Category: Neurology Source Type: research
Prasugrel or clopidogrel for long-term secondary stroke prevention?
Publication date: March 2019Source: The Lancet Neurology, Volume 18, Issue 3Author(s): Graeme J Hankey
Source: The Lancet Neurology - February 14, 2019 Category: Neurology Source Type: research
The global burden of stroke: persistent and disabling
Publication date: Available online 11 March 2019Source: The Lancet NeurologyAuthor(s): Philip B Gorelick
Source: The Lancet Neurology - March 12, 2019 Category: Neurology Source Type: research
News from the International Stroke Conference, 2019
Publication date: April 2019Source: The Lancet Neurology, Volume 18, Issue 4Author(s): Helen Frankish
Source: The Lancet Neurology - March 16, 2019 Category: Neurology Source Type: research
Stroke epidemiology in China: which are the next steps?
Publication date: April 2019Source: The Lancet Neurology, Volume 18, Issue 4Author(s): Michael Brainin
Source: The Lancet Neurology - March 16, 2019 Category: Neurology Source Type: research
Reperfusion in acute ischaemic stroke by sonothrombolysis
Publication date: April 2019Source: The Lancet Neurology, Volume 18, Issue 4Author(s): Maxime Gauberti
Source: The Lancet Neurology - March 16, 2019 Category: Neurology Source Type: research
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial
Publication date: Available online 18 March 2019Source: The Lancet NeurologyAuthor(s): Magdy Selim, Lydia D Foster, Claudia S Moy, Guohua Xi, Michael D Hill, Lewis B Morgenstern, Steven M Greenberg, Michael L James, Vineeta Singh, Wayne M Clark, Casey Norton, Yuko Y Palesch, Sharon D Yeatts, Monica Dolan, Erlinda Yeh, Kevin Sheth, Kimberly Kunze, Susanne Muehlschlegel, Iryna Nieto, Jan ClaassenSummaryBackgroundIron from haemolysed blood is implicated in secondary injury after intracerebral haemorrhage. We aimed to assess the safety of the iron chelator deferoxamine mesylate in patients with intracerebral haemorrhage and to...
Source: The Lancet Neurology - March 19, 2019 Category: Neurology Source Type: research
Small vessel disease: mechanisms and clinical implications
Publication date: Available online 13 May 2019Source: The Lancet NeurologyAuthor(s): Joanna M Wardlaw, Colin Smith, Martin DichgansSummarySmall vessel disease is a disorder of cerebral microvessels that causes white matter hyperintensities and several other common abnormalities (eg, recent small subcortical infarcts and lacunes) seen on brain imaging. Despite being a common cause of stroke and vascular dementia, the underlying pathogenesis is poorly understood. Research in humans has identified several manifestations of cerebral microvessel endothelial dysfunction including blood–brain barrier dysfunction, impaired vasod...
Source: The Lancet Neurology - May 14, 2019 Category: Neurology Source Type: research
The uncertain role for phosphodiesterase inhibitors in stroke prevention
Publication date: June 2019Source: The Lancet Neurology, Volume 18, Issue 6Author(s): Michael D Hill, Oscar R Benavente
Source: The Lancet Neurology - May 22, 2019 Category: Neurology Source Type: research
Dopamine for motor recovery after stroke: where to from here?
Publication date: June 2019Source: The Lancet Neurology, Volume 18, Issue 6Author(s): Cathy M Stinear
Source: The Lancet Neurology - May 22, 2019 Category: Neurology Source Type: research
Adding stroke to the political agenda in Europe
Publication date: June 2019Source: The Lancet Neurology, Volume 18, Issue 6Author(s): The Lancet Neurology
Source: The Lancet Neurology - May 22, 2019 Category: Neurology Source Type: research
Can cerebral microbleeds predict stroke recurrence?
Publication date: Available online 23 May 2019Source: The Lancet NeurologyAuthor(s): Georgios Tsivgoulis, Aristeidis H Katsanos
Source: The Lancet Neurology - May 23, 2019 Category: Neurology Source Type: research
